Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 25 - Drugs for disorders of the nervous system
Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
05/2003
05/21/2003EP1311283A2 Omega-conopeptides
05/21/2003EP1311272A1 Novel methods using cholinesterase inhibitors
05/21/2003EP1311270A1 Non-sedating barbiturate compounds as neuroprotective agents
05/21/2003EP1311267A1 A retroviral immunotherapy
05/21/2003EP1311265A2 Pharmaceutical compositions for treating neurological disorders
05/21/2003EP1311263A2 Fused pyrrolocarbazoles against inflammation
05/21/2003EP1311256A2 Use of derivatives of valproic acid amides and 2-valproenic acid amides for the treatment or prevention of pain and/or headache disorders
05/21/2003EP1311251A2 Use of dopamine d2/d3 receptor agonists to treat fibromyalgia
05/21/2003EP1311249A1 Transdermal therapeutic system
05/21/2003EP1311248A1 Transdermal therapeutic system for treating restless-legs-syndrome
05/21/2003EP1311245A1 Hybrid neuroprosthesis for the treatment of brain disorders
05/21/2003EP1311236A1 Use of beta-mannosylglycerate and derivatives in cosmetic and dermatological formulations
05/21/2003EP1192161B1 Chromeno[4,3,2-de]isoquinolines as potent dopamine receptor ligands
05/21/2003EP1147114B1 Novel aralkyl amines of spirofuropyridines useful in therapy
05/21/2003EP1129096B1 Crf receptor antagonists and methods relating thereto
05/21/2003EP1039802B1 Transdermal therapeutic device with capsaicin and capsaicin analogs
05/21/2003EP1014985B1 A combination of a 5-ht reuptake inhibitor and a h5-ht 1b antagonist or partial agonist
05/21/2003EP0996468B1 Conjugates of galactose-binding lectins and clostridial neurotoxins as analgesics
05/21/2003EP0981348B1 The use of levobupivacaine in paediatric surgery
05/21/2003EP0981347B1 The use of levobupivacaine in facial surgery
05/21/2003EP0981334B1 Swallow tablet comprising paracetamol
05/21/2003EP0971709B1 Novel compounds useful as neuro-protective agents
05/21/2003EP0964863B1 Oxazolidines as 5-ht2a-antagonists
05/21/2003EP0874818B1 Novel substituted aryl compounds useful as modulators of acetylcholine receptors
05/21/2003EP0851855B9 Acylated derivatives of melatonin and its analogues, useful as medicaments
05/21/2003CN1419563A Peptide derivative
05/21/2003CN1419559A Tricyclic protein kinase inhibitors
05/21/2003CN1419554A Process for preparing crystalline form 1 of cabergoline
05/21/2003CN1419552A 2-amino-3-(alkyl)-pyrimidone derivatives as GSKS beta. inhibitors
05/21/2003CN1419546A 4,5-dihydro-1h-pyrazole derivatives having cbi-antagonistic activity
05/21/2003CN1419541A Pharmaceutically active pyrrolidine derivatives as BAX inhibitors
05/21/2003CN1419539A Amidino compound and salts thereof useful as nitric oxide synahase inhibitors
05/21/2003CN1419534A Diphenyl ether compounds useful in therapie
05/21/2003CN1419448A Remedies
05/21/2003CN1419445A Agent and binding agent for pharmaceutical formulations with improved storage stability
05/21/2003CN1419444A Pharmaceutical composition of topiramate
05/21/2003CN1418869A 2-propyl valeramide and 2-propyl pentaenuylamide derivative and application used as anti-convulsion medicine
05/21/2003CN1418699A Naolingsu Kawa masticatory tablet for treating sleepless and preparation method thereof
05/21/2003CN1418697A External application medicinal liquor for treating trigeminal neural gia, and its prepn. method
05/21/2003CN1418681A Medicine compositions for treating head-ache, and its prepn. method
05/21/2003CN1418670A Traditional Chinese medicine for treating psychosis
05/21/2003CN1418654A Pain-relieving capsule, and its prepn. process
05/21/2003CN1418647A Traditional Chinese medicine oral liquid for preventing and treating psychosis, and its prepn. method
05/21/2003CN1418631A Zopiclone oral disintegrant for treating insomnia, and its prepn. method
05/21/2003CN1418628A Fentanyl oral disintegrant for treating pain, and its prepn. method
05/21/2003CN1109033C 8-subtituted-9H-1,3-dioxolo/4,5-h/2, 2/henzodiazepine derivatives, as Ampa/kainate receptor inhibitors
05/21/2003CN1108967C Metering valve
05/21/2003CN1108799C Use of K-252A derivative for treatment of peripheral or central nerve disorders, and cytokine overproduction
05/21/2003CN1108793C Use of isovaleramide as a mild anxiolytic and milk sedative agent
05/21/2003CN1108791C Galenic formula with extended release of milnacipran
05/21/2003CN1108790C Pharmaceutical compostion for transdermic delivery
05/20/2003WO2003044037A2 Process for the manufacture of human mononuclear phagocytic leukocytes
05/20/2003US6566566 Dimerization of a C6-12 olefin mixture in which the hexene isomer fraction has less than 30% by weight of linear isomers in the presence of a nickel catalyst; derivatization to give primary alcohols, and optional subsequent alkoxylation
05/20/2003US6566543 2-arachidonylglycerol (2-AG)-an inhibitor of tumor necrosis factor-α and neuroprotector of brain in closed head injury
05/20/2003US6566540 Anidepressant
05/20/2003US6566506 Useful in extending the in vivo circulating life of biologically active materials
05/20/2003US6566405 Drugs, cosmetics or dietary supplements; immunomodulation, antiallergens (IgE mediated allergies, e.g., asthma, rhinitis, eczema); anaphylaxis; autoimmune disorders, e.g., Crohn's disease, antiarthritic and ulcer agents; analgesics
05/20/2003US6566389 For prophylaxis and therapy of tardive dyskensia
05/20/2003US6566387 For therapy of psoriasis, atopic dermatitis, arthritis, asthma, chronic obstructive pulmonary disease, adult respiratory distress syndrome, inflammatory bowel disease, Crohn's disease, ulcerative colitis, stroke, septic shock
05/20/2003US6566377 Have utility as, inter alia, hypoglycemic, and anti-obesity agents.
05/20/2003US6566370 Administering decahydroisoquinoline-3-carboxylic acid derivative for therapy of migraine
05/20/2003US6566367 Spiro[isobenzofuran-1,4′-piperidin]-3-ones and 3H-spiroisobenzofuran-1,4′-piperidines
05/20/2003US6566359 For use as platelet- activating factor antagonists, inhibitors of certain protein kinases, transcriptional inhibitors of COX-2(cyclooxygenase-2) expression, and as agents in protecting brain tissue from injuries related to trauma
05/20/2003US6566356 3-amido or 3-sulfonylamino azetidine compounds and their preparation; high affinity for cannabinoid receptor CB1 type, useful in treating central nervous system, immune, gastrointestinal or cardiovascular disorders, drug abuse
05/20/2003US6566352 Administering alpha -hydroxy-2-methylene-19-nor-pregnacalciferol compound for therapy of psoriasis
05/20/2003US6566325 And isolated nucleic acids containing coding regions of genes encoding such proteins; for use in gene therapy treatment of cancer, autoimmune diseases, viral diseases
05/20/2003US6566092 Nucleotide sequences coding polypeptide for use in the treatment nervous system disorders
05/20/2003US6566080 Assay for and uses of peptide hormone receptor agonists
05/20/2003US6566065 Diagnosing schizophrenia in humans; obtain sample, analyze the methylenetetrahydrofolate reductase nucleic acid expression in sample, genotype sample, presence of mutation indicates schizophrenia
05/20/2003US6565883 Delay dissolving in water, gastric juice
05/20/2003US6565876 Carnitine and inositol phosphate-containing composition useful as dietary supplement or drug
05/20/2003US6565875 Microcapsules for administration of neuroactive agents
05/20/2003US6565848 Cadherin-like asymmetry protein-1, and methods for its use
05/20/2003US6565831 Methods for preventing reovirus recognition for the treatment of cellular proliferative disorders
05/20/2003US6565829 Psychological disorders; central nervous system disorders
05/20/2003CA2363469A1 Diagnosis of the parkinsonian condition
05/20/2003CA2117059C Pyrido-pyridazinone and pyridazinthione compounds
05/20/2003CA2110693C Amino acid derivative anticonvulsant
05/15/2003WO2003040371A1 Novel g protein-coupled receptor protein and dna thereof
05/15/2003WO2003040366A2 Inhibitor oligonucleotides and their use for specific repression of a gene
05/15/2003WO2003040358A1 Somatic cell derived embryonic stem cells and its differentiated cells
05/15/2003WO2003040345A2 Type 2 cytokine receptor and nucleic acids encoding same
05/15/2003WO2003040339A2 Antisense modulation of purinoreceptor p2x¿3?
05/15/2003WO2003040333A2 Methods for inhibiting proliferation of astrocytes and astrocytic tumor cells and for enhancing survival of neurons and uses thereof
05/15/2003WO2003040329A2 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
05/15/2003WO2003040183A2 Compounds for the diagnosis/prevention/treatment of alzheimer's disease
05/15/2003WO2003040174A2 Substituted amino ketone compounds
05/15/2003WO2003040164A2 Antigen arrays presenting il-5, il-3 or eotaxin for treatment of allergic eosinophilic diseases
05/15/2003WO2003040147A1 Azabicyclic-substituted-heteroaryl compounds for the treatment of disease__________________________________________________________________________________________________________________________
05/15/2003WO2003040144A2 Heterocyclic compound based on n6-substituted adenine, methods of their preparation, their use for preparation of drugs, cosmetic preparations and growth regulators, pharmaceutical preparations, cosmetic preparations and growth regulators containing these compounds
05/15/2003WO2003040142A1 2-amino-4-heteroarylethyl thiazoline derivatives and their use an inhibitors of inducible no-synthase
05/15/2003WO2003040134A1 Methods for preparing an estrogenic preparation and isolated estrogenic compounds from a plant and uses thereof
05/15/2003WO2003040128A1 Pyridine derivatives as nmda receptor ligands
05/15/2003WO2003040125A1 Piperazine derivatives having sst1 antagonistic activity
05/15/2003WO2003040122A1 Novel mandelate salts of substituted tetracyclic tetrahydrofuran derivatives
05/15/2003WO2003040121A1 Methods for treating depression and other cns disorders using enantiomerically enriched desmethyl- and didesmethyl-metabolites of citalopram
05/15/2003WO2003040118A1 Novel 1,2,4-thiadiazolium derivatives as melanocortin receptor modulators
05/15/2003WO2003040117A1 Novel 1,2,4-thiadiazole derivatives as melanocortin receptor modulators
05/15/2003WO2003040115A1 2-amino-thiazoline derivatives and their use as inhibitors of inducible no-synthase
05/15/2003WO2003040110A1 Triazole derivatives as cyclooxygenase (cox) inhibitors
1 ... 1213 1214 1215 1216 1217 1218 1219 1220 1221 1222 1223 1224 1225 1226 1227 1228 1229 1230 1231 1232 1233 ... 1833